Jci_page_head_homepage_01 Jci_page_head_homepage_02
Nicolas Christoforou, Ronald A. Miller, Christine M. Hill, Chunfa C. Jie, Andrew S. McCallion, John D. Gearhart
Published in Volume 118, Issue 3
J Clin Invest. 2008; 118(3):894–903 doi:10.1172/JCI33942
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 4
Differentiation capacity and differentiation efficiency of mES cell–derived CPCs.

FACS-sorted CPCs were cultured for 7 days in high serum culture medium (condition I), no serum culture medium (condition II), or high serum culture medium plus VEGF (condition III). (A) RT-PCR analysis on RNA isolated from FAC sorted and differentiated CPCs. Transcripts analyzed included cardiac markers Nkx2-5, Isl1, Flk1, Myocd, Mef2c, Gata4, Myl4, and Tnnt2; smooth muscle markers Acta2 and Myh11; endothelial marker Cdh5; stem cell markers Kit and Nanog; skeletal muscle marker Myod1; hepatic marker Afp; and the positive control marker Gapdh. Temporally matched FACS-sorted and differentiated GFP mES cells expressed high levels of ES cell markers Pou5f1 (not shown) and Nanog. (B) Efficiency of GFP+ CPC and GFP cell differentiation into cardiomyocytes (Actn1), smooth muscle cells (Acta2), and endothelial cells (Cd31) as assayed by FACS analysis.